In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Brian Bossetta

Senior Writer, US Policy & Regulation

New York, NY
After moving to New York from his hometown of New Orleans, Brian worked on the East End of Long Island covering news, politics and the military. He has since covered the diamond and jewelry industries and most recently pharmacy and healthcare. His experience also includes freelance reporting and photography contributed to the New York Times.

Brian holds a BA in history from Loyola University of New Orleans, is a die-hard Saints fan, and loves running, classical music and jazz. He lives with his wife, Caroline, in New York’s magnificent Hudson Valley. 

Latest From Brian Bossetta

Listen Up! Big Things Happening In The World Of Audiology

From innovation to legislation, the US audiology market is being shaped by cutting-edge technology from device makers and legislation from the Biden administration to get more hearing aids to those that need them.

Outlook 2022 Commercial

FDA Posts Study Confirming OD Risk From ENFit LDT Syringes

The US FDA has posted a study affirming a safety communication the agency issued in October that warned of overdose risk from certain low dose tip syringes.

Safety FDA

FDA Warns Of Severe Risks Associated With Medtronic Leadless Pacemakers

The US Food and Drug Administration has issued a warning to clinicians of the heightened risk for adverse events, including death, from potential cardiac perforation during implantation of Medtronic’s Micra Transcatheter Pacing System (TPS).

Safety FDA

Exec Chat: Intricon CEO Bullish On OTC Hearing Aids

Scott Longval, CEO of medical device manufacturer Intricon, says the US FDA’s proposal to allow over-the-counter sales of hearing aids without a prescription will benefit industry as well as those with hearing loss.

Exec Chats FDA

FDA Gives Green Light To Non-Opioid Treatment For Back Pain

The US Food and Drug Administration has authorized a virtual reality system for treating chronic lower back pain. EaseVRx uses a virtual reality headset and sound amplifier to assist in breathing exercises aimed at reducing pain.

FDA Approvals

US FDA Updates Template For OTC COVID-19 Test Development

The US FDA’s most recent update is intended to help test makers provide validation data and other information to the agency for developing at-home diagnostic tests.

Coronavirus COVID-19 FDA
See All
UsernamePublicRestriction

Register